Backing the Bio-Century.
This belief guides how Cavano Capital selects companies and supports founders. It is the core distinction from generalist capital at the same stages.
USD 750k – 3M
Founders who treat regulatory design and manufacturing economics as part of the product. Repeatable data and credible bio-industrial partners carry more weight than pitch-deck storytelling.
Translational velocity is the primary signal. We monitor the time from core discovery to IRB-approved protocol and from batch to validated COGS. Cavano Capital values deep IP and early line-of-sight to sovereign customers.
From first meeting to term sheet, we run a lab‑style sprint:
Scientific and IP Review
Regulatory and Manufacturing Mapping
Structured Term Sheet for Aligned Founders